EXPERIMENTAL ALLERGIC NEURITIDES
\ɛkspˌɛɹɪmˈɛntə͡l ɐlˈɜːd͡ʒɪk njˈuːɹɪtˌa͡ɪdz], \ɛkspˌɛɹɪmˈɛntəl ɐlˈɜːdʒɪk njˈuːɹɪtˌaɪdz], \ɛ_k_s_p_ˌɛ_ɹ_ɪ_m_ˈɛ_n_t_əl ɐ_l_ˈɜː_dʒ_ɪ_k n_j_ˈuː_ɹ_ɪ_t_ˌaɪ_d_z]\
Sort: Oldest first
-
An experimental animal demyelinating disease model of GUILLAINE-BARRE SYNDROME. In the most frequently used protocol, animals are injected with a peripheral nerve tissue protein homogenate. After approximately 2 weeks the animals develop a neuropathy secondary to a T cell-mediated autoimmune response directed towards the MYELIN P2 PROTEIN in peripheral nerves. Pathologic findings include a perivascular accumulation of macrophages and T lymphocytes in the peripheral nervous system, similar to that seen in the Guillaine-Barre syndrome. (From Adams et al., Principles of Neurology, 6th ed, p1314; J Neuroimmunol 1998 Apr 1;84 (1):40-52)
By DataStellar Co., Ltd
